HomeInsightsMarket Capitalization

Market Capitalization of Astrazeneca Pharma India Ltd

Market Capitalization of Astrazeneca Pharma India Ltd

stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

0.3 K

stocks traded

Last Updated time: 05 Nov 12:15 PM

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

MARKETCAP

18448.5 crore

Last updated on: Nov 04, 2024

Key Highlights

  • The Market Cap of Astrazeneca Pharma India Ltd is ₹ 18448 crore as of 04 Nov 24.
  • The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 4995 crore on March 2019 to ₹ 13301 crore on March 2024 . This represents a CAGR of 17.73% over 6 years. .
  • The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 7350 as of 05 Nov 12:08.

Historical Market Cap of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Company Fundamentals for Astrazeneca Pharma India Ltd

No data available

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

PRICE

7350

-29.40 (-0.40%)

stock direction

Last updated on: Nov 05 12:08 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20247379.4
01 Nov 20247550.3
31 Oct 20247606.7
30 Oct 20247349.05
29 Oct 20247386.55
28 Oct 20247055.65
25 Oct 20247139.75
24 Oct 20247160.85
23 Oct 20247211.05
22 Oct 20247182.95

BlinkX Score for Astrazeneca Pharma India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Astrazeneca Pharma India Ltd

No data available

Historical P/E Ratio of Astrazeneca Pharma India Ltd

No data available

* All values are in %

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical EBITDA of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Dividend Payout of Astrazeneca Pharma India Ltd

No data available

* All values are in %

About Astrazeneca Pharma India Ltd

  • AstraZeneca Pharma India (APIL) was incorporated on July 11, 1979.
  • The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
  • The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
  • Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

Astrazeneca Pharma India Ltd News Hub

News

Astrazeneca Pharma India to announce Quarterly Result

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...

Read more

25 Oct 202416:11

News

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed b...

Read more

24 Sep 202408:54

News

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and Nation...

Read more

24 Sep 202412:00

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Schneider Electric Infrastructure Lt...

Read more

24 Sep 202414:30

News

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter...

Read more

08 Aug 202416:08

News

Astrazeneca Pharma India to hold board meeting

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 8...

Read more

24 Jul 202416:06

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Astrazeneca Pharma India Ltd Market Cap

What is the market cap of Astrazeneca Pharma India Ltd?

As of November 5, 2024, Astrazeneca Pharma India Ltd has a market capitalization of ₹18448.5, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Astrazeneca Pharma India Ltd's market capitalization?

Astrazeneca Pharma India Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Astrazeneca Pharma India Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Astrazeneca Pharma India Ltd's market capitalization change?

Astrazeneca Pharma India Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*